CoMFA and CoMSIA 3D-QSAR studies on S(6)-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) analogs as inhibitors of human equilibrative nucleoside transporter 1 (hENT1).
3D-QSAR (CoMFA and CoMSIA) studies were performed on human equlibrative nucleoside transporter (hENT1) inhibitors displaying K(i) values ranging from 10,000 to 0.7nM. Both CoMFA and CoMSIA analysis gave reliable models with q2 values >0.50 and r2 values >0.92. The models have been validated for their stability and robustness using group validation and bootstrapping techniques and for their predictive abilities using an external test set of nine compounds. The high predictive r2 values of the test set (0.72 for CoMFA model and 0.74 for CoMSIA model) reveals that the models can prove to be a useful tool for activity prediction of newly designed nucleoside transporter inhibitors. The CoMFA and CoMSIA contour maps identify features important for exhibiting good binding affinities at the transporter, and can thus serve as a useful guide for the design of potential equilibrative nucleoside transporter inhibitors.
Gupte
Amol
A
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Sciences Center, 847 Monroe Avenue Suite 327, Memphis, TN 38163, USA.
Buolamwini
John K
JK
D033721:Equilibrative Nucleoside Transporter 1 / Q000037:antagonists & inhibitors*; D006801:Humans; D008958:Models, Molecular; D021281:Quantitative Structure-Activity Relationship; D013868:Thioinosine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology
D033721:Equilibrative Nucleoside Transporter 1; C438649:SLC29A1 protein, human; D013868:Thioinosine; C001789:4-nitrobenzylthioinosine